je.st
news
Tag: merck
Merck to Present New Data on ZEPATIER (elbasvir and grazoprevir) and Chronic Hepatitis C Clinical Development Programs at The Liver Meeting 2016
2016-10-03 14:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced that new data from the companys chronic hepatitis C virus (HCV) clinical development programs will be presented at The Liver Meeting 2016. Fifteen scientific abstracts, including seven oral and eight poster presentations, will highlight findings from Mercks HCV clinical development programs. Language: English Contact: MerckMedia:Doris Li, 908-740-1903Ian McConnell, 908-740-1921orInvestors:Teri Loxam, 908-740-1986Amy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: the
data
development
present
Merck Congratulates Guatemala as Fourth Country in Latin America to Achieve WHO Verification of Elimination of River Blindness
2016-09-29 19:06:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, commends the government of Guatemala on being the fourth country in Latin America to receive World Health Organization (WHO) verification of the elimination of river blindness (onchocerciasis). Language: English Contact: MerckLainie Keller, 908-236-5036 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: of
country
america
river
Merck Foundation Grant Expands YMCAs Diabetes Prevention Program in Five States
2016-09-29 15:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. $2 Million Grant Boosts Efforts to Prevent Type 2 Diabetes in Participants with Prediabetes KENILWORTH, N.J.--(BUSINESS WIRE)--The Merck Foundation and YMCA of the USA (Y-USA) announced today that the Merck Foundation has provided a grant of $2 million over three years to support efforts to expand the YMCAs Diabetes Prevention Program (YMCAs DPP). This evidence-based, chronic disease prevention program aims to improve the health of participants with prediabetes through modest weight loss achieved by healthy eating and physical activity. Language: English Contact: Merck Media:Lainie Keller, (908) 236-5036orJeanine Clemente, (908) 236-5059orYMCA Media:Kevin Dietz, (312) 419-8418 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: program
states
foundation
grant
Merck to Hold Third-Quarter 2016 Sales and Earnings Conference Call on October 25
2016-09-23 14:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, will hold its third-quarter 2016 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EDT on Tuesday, Oct. 25. During the call, company executives will provide an overview of Mercks performance for the quarter. Language: English Contact: MerckMedia:Lainie Keller, 908-236-5036orInvestors:Teri Loxam, 908-740-1986Amy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Merck to Host Investor Teleconference to Discuss ESMO 2016 Highlights
2016-09-20 14:30:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, will host a teleconference for investors following the presentation of data at the European Society for Medical Oncology (ESMO) 2016 Congress in Copenhagen, Denmark, Oct. 7 11. The call will take place on Sunday, Oct. 9 at 6:30 p.m. CEST (12:30 p.m. EDT). Company executives will provide an overview of data presented and address questions. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Kim Hamilton, 908-740-1863orInvestors:Teri Loxam, 908-740-1986Amy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: discuss
host
investor
highlights
Sites : [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] next »